Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2015, Article ID 481670, 7 pages
http://dx.doi.org/10.1155/2015/481670
Research Article

Investigation of Fatty Acid Ketohydrazone Modified Liposome’s Properties as a Drug Carrier

1Department of Chemical Engineering, National Institute of Technology, Nara College, 22 Yata-cho, Yamatokoriyama, Nara 639-1080, Japan
2Division of Chemical Engineering, Graduate School of Engineering Science, Osaka University, 1-3 Machikaneyama-cho, Toyonaka, Osaka 560-8531, Japan

Received 25 July 2015; Revised 2 October 2015; Accepted 18 October 2015

Academic Editor: Subbu S. Venkatraman

Copyright © 2015 Keita Hayashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Zhai and G. Zhai, “Advances in lipid-based colloid systems as drug carrier for topic delivery,” Journal of Controlled Release, vol. 193, pp. 90–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Wiedersberg and R. H. Guy, “Transdermal drug delivery: 30 + years of war and still fighting!,” Journal of Controlled Release, vol. 190, pp. 150–156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. V. Natarajan, C. Nugraha, X. W. Ng, and S. Venkatraman, “Sustained-release from nanocarriers: a review,” Journal of Controlled Release, vol. 193, pp. 122–138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Mross, B. Niemann, U. Massing et al., “Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study,” Cancer Chemotherapy and Pharmacology, vol. 54, no. 6, pp. 514–524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. E. Lipshultz, S. D. Colan, R. D. Gelber, A. R. Perez-Atayde, S. E. Sallan, and S. P. Sanders, “Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood,” The New England Journal of Medicine, vol. 324, no. 12, pp. 808–815, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Maruyama, “Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects,” Advanced Drug Delivery Reviews, vol. 63, no. 3, pp. 161–169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. O. V. Gerasimov, J. A. Boomer, M. M. Qualls, and D. H. Thompson, “Cytosolic drug delivery using pH- and light-sensitive liposomes,” Advanced Drug Delivery Reviews, vol. 38, no. 3, pp. 317–338, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Verrill, “Anthracyclines in breast cancer: therapy and issues of toxicity,” The Breast, vol. 10, supplement 2, pp. 8–15, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-S. Lee, W. Park, S.-J. Park, and K. Na, “Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption,” Biomaterials, vol. 34, no. 36, pp. 9227–9236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Levacheva, O. Samsonova, E. Tazina et al., “Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof,” Colloids and Surfaces B: Biointerfaces, vol. 121, pp. 248–256, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Wienisch and J. Klingauf, “Vesicular proteins exocytosed and subsequently retrieved by compensatory endocytosis are nonidentical,” Nature Neuroscience, vol. 9, no. 8, pp. 1019–1027, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. Kale and V. P. Torchilin, “‘Smart’ drug carriers: PEGylated TATp-modified pH-sensitive liposomes,” Journal of Liposome Research, vol. 17, no. 3-4, pp. 197–203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Farhood, N. Serbina, and L. Huang, “The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer,” Biochimica et Biophysica Acta, vol. 1235, no. 2, pp. 289–295, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. M. R. Moncelli, L. Becucci, and R. Guidelli, “The intrinsic pKa values for phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine in monolayers deposited on mercury electrodes,” Biophysical Journal, vol. 66, no. 6, pp. 1969–1980, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. A. D. Petelska, M. Naumowicz, and Z. A. Figaszewski, “The influence of pH on phosphatidylethanolamine monolayer at the air/aqueous solution interface,” Cell Biochemistry and Biophysics, vol. 65, no. 2, pp. 229–235, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Xu and F. C. Szoka Jr., “Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection,” Biochemistry, vol. 35, no. 18, pp. 5616–5623, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Rodrigues, Y. Canac, and A. Lubineau, “A convenient, one-step, synthesis of β-C-glycosidic ketones in aqueous media,” Chemical Communications, no. 20, pp. 2049–2050, 2000. View at Google Scholar
  18. K. Hayashi, T. Shimanouchi, K. Kato, T. Miyazaki, A. Nakamura, and H. Umakoshi, “Span 80 vesicles have a more fluid, flexible and “wet” surface than phospholipid liposomes,” Colloids and Surfaces B: Biointerfaces, vol. 87, no. 1, pp. 28–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Shimanouchi, H. Ishii, N. Yoshimoto, H. Umakoshi, and R. Kuboi, “Calcein permeation across phosphatidylcholine bilayer membrane: effects of membrane fluidity, liposome size, and immobilization,” Colloids and Surfaces B: Biointerfaces, vol. 73, no. 1, pp. 156–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Hayashi, T. Tatsui, T. Shimanouchi, and H. Umakoshi, “Enhanced cytotoxicity for Colon 26 cells using Doxorubicin-loaded sorbitan monooleate (Span 80) vesicles,” International Journal of Biological Sciences, vol. 9, no. 2, pp. 142–148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Parasassi, M. Di Stefano, M. Loiero, G. Ravagnan, and E. Gratton, “Influence of cholesterol on phospholipid bilayers phase domains as detected by Laurdan fluorescence,” Biophysical Journal, vol. 66, no. 1, pp. 120–132, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Patil, J. Portilla-Arias, H. Ding et al., “Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-L-malic acid),” International Journal of Molecular Sciences, vol. 13, no. 9, pp. 11681–11693, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Koynova and M. Caffrey, “Phases and phase transitions of the phosphatidylcholines,” Biochimica et Biophysica Acta, vol. 1376, no. 1, pp. 91–145, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Hayashi, T. Tatsui, T. Shimanouchi, and H. Umakoshi, “Membrane interaction between Span 80 vesicle and phospholipid vesicle (liposome): Span 80 vesicle can perturb and hemifuse with liposomal membrane,” Colloids and Surfaces B: Biointerfaces, vol. 106, pp. 258–264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Han, “Molecular dynamics simulation of oleic acid/oleate bilayers: an atomistic model for a ufasome membrane,” Chemistry and Physics of Lipids, vol. 175-176, pp. 79–83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Maeda, “The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting,” Advances in Enzyme Regulation, vol. 41, no. 1, pp. 189–207, 2001. View at Publisher · View at Google Scholar · View at Scopus